A strain of the Newcastle disease virus, denoted GF, was isolated from birds vaccinated twice with a live vaccine. In some flocks of the farm this strain has caused oligosymptomatic disease, and in others the infection has run a latent course. It was shown that the GF strain possessed unusual biologic properties--an extremely high virulence in vitro combined with a total lack of pathogenicity in vivo. With regard to the tests mean death time with 10-day-old chick embryos (44.6 h) and plaque morphology (a heterogeneous plaque population of clear plaques, sizing 0.5 to 3.5 mm) it was referred to the velogenic group. With regard to the intracerebral pathogenic index (1.21) it belonged to the mesogenic group. In terms of the intravenous pathogenic index (0) it had to be classified with the lentogenic group of of strains of the Newcastle disease virus. All these properties of the strain were shown to be stable. Besides the difficulties with its differentiation the behaviours of this strain pose a number of problems with regard to its origin and the variability of the Newcastle disease virus in nature, which are subject to discussion.

Download full-text PDF

Source

Publication Analysis

Top Keywords

newcastle disease
12
disease virus
12
strain
5
[characteristics newcastle
4
virus
4
newcastle virus
4
virus isolated
4
isolated live
4
live vaccine-immunized
4
vaccine-immunized chickens--the
4

Similar Publications

Genetic diagnosis of rare diseases requires accurate identification and interpretation of genomic variants. Clinical and molecular scientists from 37 expert centers across Europe created the Solve-Rare Diseases Consortium (Solve-RD) resource, encompassing clinical, pedigree and genomic rare-disease data (94.5% exomes, 5.

View Article and Find Full Text PDF

Diffuse coronary artery disease (CAD) impacts the immediate hemodynamic and clinical outcomes of percutaneous coronary intervention (PCI). We evaluated whether the diffuse pattern of CAD derived from angiographic Quantitative flow ratio (QFR) impacts the immediate hemodynamic outcome post-PCI and the medium term predicted vessel-oriented composite endpoint (VOCE). Paired pre-procedure QFRs were assessed in 503 patients and 1022 vessels in the Multivessel TALENT (MVT) trial.

View Article and Find Full Text PDF

Background: Aspirin is a simple, globally available medication that has been shown to reduce the incidence of colorectal cancer. We aimed to evaluate the safety and efficacy of aspirin in the secondary prevention of colorectal cancer.

Methods: This phase 3, randomised, double-blind, placebo-controlled trial was conducted at 66 centres across 11 countries and territories (ten in Asia-Pacific; one in the Middle East).

View Article and Find Full Text PDF

Large-scale evaluation of outcomes after a genetic diagnosis in children with severe developmental disorders.

Genet Med Open

October 2024

Department of Clinical and Biomedical Sciences, Medical School, University of Exeter, St Luke's Campus, Exeter, United Kingdom.

Purpose: We sought to evaluate outcomes for clinical management after a genetic diagnosis from the Deciphering Developmental Disorders study.

Methods: Individuals in the Deciphering Developmental Disorders study who had a pathogenic/likely pathogenic genotype in the DECIPHER database were selected for inclusion ( = 5010). Clinical notes from regional clinical genetics services notes were reviewed to assess predefined clinical outcomes relating to interventions, prenatal choices, and information provision.

View Article and Find Full Text PDF

Influenza vaccine effectiveness and immunogenicity can be compromised with repeated vaccination. We assessed immunological markers in a cohort of healthcare workers (HCW) from six public hospitals around Australia during 2020-2021. Sera were collected pre-vaccination and ~14 and ~180 days post-vaccination and assessed in haemagglutination inhibition assay against egg-grown vaccine and equivalent cell-grown viruses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!